- Home
- CTS vs INVA Comparison
CTS vs INVA Comparison
Compare CTS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTS | INVA |
|---|---|---|
| Founded | 1896 | 1996 |
| Country | United States | United States |
| Employees | 3492 | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | CTS | INVA |
|---|---|---|
| Price | $64.80 | $22.90 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.80 |
| AVG Volume (30 Days) | 258.0K | ★ 625.7K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | 15.87 | ★ 816.67 |
| EPS | 0.59 | ★ 2.22 |
| Revenue | ★ $541,318,000.00 | $217,217,000.00 |
| Revenue This Year | $5.55 | $8.95 |
| Revenue Next Year | $5.00 | $12.65 |
| P/E Ratio | $105.32 | ★ $10.12 |
| Revenue Growth | 4.95 | ★ 62.63 |
| 52 Week Low | $36.03 | $16.52 |
| 52 Week High | $62.23 | $25.15 |
Technical Indicators
Market Signals| Indicator | CTS | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 68.55 | 52.46 |
| Support Level | $40.08 | $21.91 |
| Resistance Level | N/A | $24.22 |
| Average True Range (ATR) | 2.08 | 0.74 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 93.96 | 56.56 |
Price Performance
Historical ComparisonAbout CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.